Posted by Michael Wonder on 31 Mar 2022
2022 April cycle - brand price reductions and savings to patients
31 March 2022 - Brand price reductions and savings to patients resulting from the 2022 April cycle of price disclosure have now been published.
A few medicines will incur substantial price reductions:
- Alendronate sodium with colecalciferol and calcium carbonate - 77,56%
- Arsenic trioxide - 49.01%
- Cabazitaxel - 37.08%
- Pegfilgrastim - 48.56%
- Rituximab - 37.12%
- Tenofovir disoproxil fumarate with emtricitabine - 34.77%
